Albireo Pharma IncのQuick ratio

Albireo Pharma IncのQuick ratioは何ですか。

Albireo Pharma IncのQuick ratioは6.23です。

Quick ratioの定義は何ですか。



当座比率は、短期債務を即座に満たすために迅速な資産を使用する企業の能力を測定する流動性比率です。

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

NASDAQのセクタHealth CareにおけるQuick ratioの企業と比べるAlbireo Pharma Inc

Albireo Pharma Incは何をしますか。

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Albireo Pharma Incと類似のquick ratio